Global Expression Vectors Market will reach USD 330.3

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Expression Vectors Market will reach USD 330.3 Million by 2021: Zion Market Research

Sarasota, FL, Dec. 28, 2016 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Expression Vectors Market (Bacterial, Yeast, Insect, and Mammalian) by Application (Therapeutic, Research, and Industrial) for Biotechnology & Pharmaceutical Companies, CROs & CMOs, and Academic Research End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021” . According to the report, the global  expression vectors market  was valued at approximately USD 240.7 million in 2015 and is expected to reach approximately USD 330.3 million by 2021, growing at a CAGR of around 5.4% between 2016 and 2021.

Expressions vector is the basic tool in biotechnology which is designed for gene expression in cells. The expression vector is used to introduce a specific gene into a target cell. The expression vector can commandeer the target cell's mechanism for the production of proteins. The cloning vector containing proper expressions signals to have maximum gene expression. Different types of vector system have been developed viz. virus vector, the bacterial vector, plasmid DNA etc.

Browse through 39 Market Tables and 19 Figures spread over 110 Pages and in-depth TOC on “Global Expression Vectors Market: By Host Type, Application, Size, Share, Growth, Analysis, Segment and Forecast 2015-2021”.

Request free Sample copy of Expression Vectors Market Report @ https://www.zionmarketresearch.com/sample/exp...ors-market

Global expression vectors market is expected to exhibit strong growth in the near future on account of the rising demand of protein-based drugs. The other key drivers influencing the growth of expression vectors market include genetic disorders, the high prevalence of infectious diseases and other diseases. Moreover, technological advancement in protein expression techniques, molecular biology, and bioinformatics is expected to propel the market growth within the forecast period. Increasing unmet medical needs due to the patent expiration of generic drugs is further projected to drive expression vectors market in order to develop novel drugs. However, high expenditure involved in research employing expression vectors may hamper the market growth in the coming years.

Bacterial, yeast, insect and mammalian expression vectors are available in the global market. In 2015, the bacterial vector was the leading segment due to high transformation levels and simple transformation protocols. The mammalian expression vectors are the key outlet of expression vector market and are expected to witness the fastest growth within the forecast period. Mammalian host systems have the ability to carry out assembly of recombinant proteins, folding, and complex post-translational modifications. 

Browse the full " Expression Vectors Market (Bacterial, Yeast, Insect, and Mammalian) by Application (Therapeutic, Research, and Industrial) for Biotechnology & Pharmaceutical Companies, CROs & CMOs, and Academic Research End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021 " report at  https://www.zionmarketresearch.com/report/exp...ors-market

Based on applications the expression vectors market can be segmented into therapeutic, industrial, and research applications. Therapeutic application accounted for the largest market share in 2015 and is expected to remain the fastest growing segment in the years to come. This growth is mainly due to the higher incidence rate of oncology diseases which can be treated by use of expression vectors. Research segment is expected to witness significant growth in the years to come. Technological advancement in proteomics and novel product for protein expression are expected to open up new avenues for the segment growth.

The expression vectors market is segmented on the basis of different end-user such as biotechnology & pharmaceutical companies, contract research organizations (CROs) & contract manufacturing organizations (CMOs), and academic research institutes. Biotechnology & pharmaceutical companies were the largest segment of expression vectors market in 2015 and are expected to continue its dominance in the near future. This growth is mainly due to the advancement in protein pharmaceuticals synthesis and novel drug using recombinant DNA technology.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/ex...ors-market

The North America regional market is by far the largest in the global expression vectors market and is set to continue to dominate the world marketplace within the forecast period. The expression vectors market is driven by the presence of research labs and production facilities of major manufacturers in this region. The rising numbers of big pharmacy firms coupled with advanced technology in the U.S. are some of the key factors that are expected to fuel the market growth in this region.

In terms of revenue, North America was followed by Europe. The therapeutic application segment is expected to propel the market growth in the years to come. This growth is mainly attributed to the increasing incidence rate of oncology diseases coupled with health awareness among people. Moreover, the adoption of new technologies is expected to witness significant growth over the forecast period. Thus, all aforementioned factors are expected to drive the demand for nanobiotechnology market in Europe.

Request a customized copy of report @ https://www.zionmarketresearch.com/custom/579

Asia Pacific is expected to fastest growing market in near future. Increasing international research collaborations, R&D expenditure, and growth in the overall healthcare industry is expected to drive growth in this region. Moreover, expression vectors market has the huge opportunity in the emerging markets of Asia Pacific due to the increasing population, rising incidence rate of oncology diseases, coupled with the rising health awareness among people especially in China and India.

The Middle East & Africa regional market is expected to witness moderate growth in the near future. The increasing demand of protein-based drugs is expected to boost the market growth in the years to come. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to technological advancement in protein expression techniques, molecular biology, and bioinformatics.

Some of the key players including in the expression vectors markets such as Promega Corporation, Agilent Technologies, New England Biolabs, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Merck Millipore, QIAGEN, Clontech Laboratories, Inc., and GenScript USA Inc.

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...ors-market

This report segments the global expression vectors market as follows:

Global Expression Vectors Market: Host Analysis

  • Bacterial
  • Yeast
  • Insect
  • Mammalian 

Global Expression Vectors Market: Application Analysis

  • Therapeutic
  • Industrial
  • Research

Global Expression Vectors Market: End-user Segment Analysis 

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • Academic Research Institutes.

Global Expression vectors Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Bollinger Motors Rolls Out Electric Trucks to Boost Production

Updated Category News Views 121

Bollinger Motors Delivers Electric Trucks Mullen Automotive, Inc. (NASDAQ: MULN), a pioneering electric vehicle manufacturer, has recently announced through its subsidiary Bollinger Motors the delivery of three Bollinger B4 chassis cab electric trucks to TEC Equipment locations. This noteworthy transaction, valued at around $500,000, was completed via electronic payment,...

Continue Reading
Exploring Abu Dhabi: A Dream Getaway with Celebrities

Updated Category News Views 37

A Perfect Escape: Elsa Pataky and Chris Hemsworth Team Up with Experience Abu Dhabi Abu Dhabi is renowned for its rich tapestry of culture, adventure, and relaxation, making it an ideal vacation destination. The enchanting city has captured the attention of Hollywood couple Elsa Pataky and Chris Hemsworth, who have united their star power with Experience Abu Dhabi to...

Continue Reading
Mesa Laboratories Announces Exciting Quarterly Dividend Updates

Updated Category News Views 129

Mesa Laboratories Declares a Quarterly Dividend Mesa Laboratories, Inc. (NASDAQ: MLAB), based in Lakewood, Colorado, has made an announcement that is attracting attention in the financial community. The Board of Directors has officially declared a regular quarterly dividend of $0.16 for each share of common stock. This dividend is set to be paid on December 15, allowing...

Continue Reading
Oma Savings Bank Strengthens Financial Resilience with New Requirements

Updated Category News Views 223

Oma Savings Bank Navigates New Financial Requirements Oma Savings Bank Plc, commonly known as OmaSp, is adapting to fresh capital and liquidity requirements as mandated by the Finnish Financial Supervisory Authority (FIN-FSA). This decision, stemming from the comprehensive review process known as SREP, is not merely a regulatory hurdle but a key step towards solidifying...

Continue Reading
Current Trends in Cryptocurrency Markets: BTC, DOGE, ETH Updates

Updated Category News Views 253

Bitcoin Sees Resistance Below $90,000 In recent trading sessions, Bitcoin has remained just under the pivotal $90,000 threshold. This situation has arisen due to factors like cooling inflation data, which has cultivated a cautious attitude among investors. The current market scenario has sparked discussions about potential future movements for Bitcoin and its rivals....

Continue Reading